机构：[1]Infectious Diseases Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.[2]Guangdong Provincial Key Laboratory of Translational Cancer Research of Chinese Medicines, Joint International Research Laboratory of Translational Cancer Research of Chinese Medicines, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.[3]Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.中山大学附属第一医院[4]Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.深圳市中医院深圳医学信息中心
第一作者机构：[1]Infectious Diseases Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Li Feng,Wang Shaogui,Chao Xiaojuan,et al.Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases[J].FRONTIERS IN PHARMACOLOGY.2023,13:doi:10.3389/fphar.2022.1121821.
APA：
Li Feng,Wang Shaogui,Chao Xiaojuan&Wang Shuai.(2023).Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases.FRONTIERS IN PHARMACOLOGY,13,
MLA：
Li Feng,et al."Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases".FRONTIERS IN PHARMACOLOGY 13.(2023)
医学